# TRial on the Endocrine Activity of Neoadjuvant Degarelix

> **NCT02005887** · PHASE2 · COMPLETED · sponsor: **ETOP IBCSG Partners Foundation** · enrollment: 51 (actual)

## Conditions studied

- Breast Cancer Invasive Nos

## Interventions

- **DRUG:** triptorelin
- **DRUG:** degarelix
- **DRUG:** letrozole

## Key facts

- **NCT ID:** NCT02005887
- **Lead sponsor:** ETOP IBCSG Partners Foundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-08-25
- **Final completion:** 2017-08-25
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005887, "TRial on the Endocrine Activity of Neoadjuvant Degarelix". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02005887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*